Business
Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product
Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product
About this update from Infant Bacterial Therapeutics Ab Class B
Infant Bacterial Therapeutics AB OMXSTO:IBT_B:SAID ON THURSDAY SECURES PARTNERSHIP WITH BIOCONNECTION FOR PRODUCTION OF DRUG PRODUCTDRUG PRODUCT PROCESS PERFORMANCE QUALIFICATION PROGRAMME TO BE CONDUCTED AT BIOCONNECTION’S MANUFACTURING FACILITY IN OSS, THE NETHERLANDS Source text for Workspace: Further company coverage: [IBTb.ST]
View stock analysis, news, and events for Infant Bacterial Therapeutics Ab Class B